Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
3 weeks ago • Google News
Xencor Inc (XNCR)
US$ 10.51-3.04%
Price Chart
Key Statistics
Market Cap
$ 573.64M
P/E Ratio
0.00
Revenue (TTM)
$ 127.23M
Volume
455.27K
52W High
$ 27.24
52W Low
$ 7.16
Dividend Yield
0.00%
Beta
0.99
Technicals
50-Day MA
10.36
200-Day MA
17.744
52 Week High
27.24
52 Week Low
7.16
About XNCR
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune dis.
Employees
250
Headquarters
Pasadena, CA
CEO
Dr. Bassil I. Dahiyat Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg